Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1861 1
1918 1
1920 1
1945 1
1946 1
1948 1
1960 1
1972 1
1984 1
1986 1
1993 1
1994 1
1995 2
1996 1
1997 1
1998 2
2000 8
2001 4
2002 15
2003 8
2004 7
2005 3
2006 7
2007 8
2008 4
2009 6
2010 6
2011 11
2012 9
2013 9
2014 9
2015 11
2016 17
2017 15
2018 27
2019 50
2020 44
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 12093340

277 results
Results by year
Filters applied: . Clear all
Page 1
A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.
Veves A, Sheehan P, Pham HT. Veves A, et al. Arch Surg. 2002 Jul;137(7):822-7. doi: 10.1001/archsurg.137.7.822. Arch Surg. 2002. PMID: 12093340 Clinical Trial.
Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries.
Ghatnekar O, Willis M, Persson U. Ghatnekar O, et al. J Wound Care. 2002 Feb;11(2):70-4. doi: 10.12968/jowc.2002.11.2.26675. J Wound Care. 2002. PMID: 11901743 Clinical Trial.
The healing properties of Promogran in venous leg ulcers.
Vin F, Teot L, Meaume S. Vin F, et al. J Wound Care. 2002 Oct;11(9):335-41. doi: 10.12968/jowc.2002.11.9.26438. J Wound Care. 2002. PMID: 12430368 Clinical Trial.
Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial.
Kakagia DD, Kazakos KJ, Xarchas KC, Karanikas M, Georgiadis GS, Tripsiannis G, Manolas C. Kakagia DD, et al. J Diabetes Complications. 2007 Nov-Dec;21(6):387-91. doi: 10.1016/j.jdiacomp.2007.03.006. J Diabetes Complications. 2007. PMID: 17967712 Clinical Trial.
Evaluation of a collagen-alginate wound dressing in the management of diabetic foot ulcers.
Donaghue VM, Chrzan JS, Rosenblum BI, Giurini JM, Habershaw GM, Veves A. Donaghue VM, et al. Adv Wound Care. 1998 May-Jun;11(3):114-9. Adv Wound Care. 1998. PMID: 9729942 Clinical Trial.
Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP, Plosker GL. Curran MP, et al. BioDrugs. 2002;16(6):439-55. doi: 10.2165/00063030-200216060-00005. BioDrugs. 2002. PMID: 12463767 Review.
Effect of oxidized regenerated cellulose/collagen matrix on proteases in wound exudate of patients with diabetic foot ulcers.
Ulrich D, Smeets R, Unglaub F, Wöltje M, Pallua N. Ulrich D, et al. J Wound Ostomy Continence Nurs. 2011 Sep-Oct;38(5):522-8. doi: 10.1097/WON.0b013e31822ad290. J Wound Ostomy Continence Nurs. 2011. PMID: 21860331
Some effects of a topical collagen-based matrix on the microcirculation and wound healing in patients with chronic venous leg ulcers: preliminary observations.
Wollina U, Schmidt WD, Krönert C, Nelskamp C, Scheibe A, Fassler D. Wollina U, et al. Int J Low Extrem Wounds. 2005 Dec;4(4):214-24. doi: 10.1177/1534734605283001. Int J Low Extrem Wounds. 2005. PMID: 16286373 Clinical Trial.
Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.
Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H. Lobmann R, et al. J Diabetes Complications. 2006 Sep-Oct;20(5):329-35. doi: 10.1016/j.jdiacomp.2005.08.007. J Diabetes Complications. 2006. PMID: 16949521 Clinical Trial.
Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment.
Gottrup F, Cullen BM, Karlsmark T, Bischoff-Mikkelsen M, Nisbet L, Gibson MC. Gottrup F, et al. Wound Repair Regen. 2013 Mar-Apr;21(2):216-25. doi: 10.1111/wrr.12020. Epub 2013 Feb 25. Wound Repair Regen. 2013. PMID: 23438054 Clinical Trial.
277 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback